Depression among adults with chronic hepatitis C on antiviral treatment in Port-Said, Egypt
- 14 Downloads
This study aimed to estimate the prevalence of depression among adults with chronic hepatitis C on antiviral treatment.
Subjects and methods
This was a cross-sectional descriptive and analytic study, conducted between January and August 2017, in two centers for hepatitis C virus treatment in Port Said governorate; one center is located in a fever hospital for non-insured persons, and the other is located in Eltadamon, which is a health insurance hospital for insured persons. It included adults with chronic hepatitis C virus infection attending the locations of the study by systematic random sampling of 288 patients. They filled out questionnaires of the Beck Depression Inventory (BDI), socioeconomic status, and medical history.
About one-third (29%) of chronic hepatitis C (CHC) patients had depression varying from mild in 16%, moderate in 6%, and severe depression in 7% of patients. Younger patients were more depressed (p = 0.009); also, females were more depressed than males (p < 0.001), unmarried patients more depressed than married patients (p = 0.014), illiterates more depressed than educated (p = 0.009), not working patients more depressed (p = 0.001), slum residents more depressed (p < 0.001), and finally lower socioeconomic status patients more depressed (p < 0.001). Increased duration of illness associated with depression (p = 0.02), and patients receiving three doses of treatment less depressed (p = 0.01).
Depression is a common problem in CHC patients; they require treatment with both antivirals and antidepressants, and patient continuation of antiviral treatment decreases the prevalence of depression. More education and improvement in socioeconomic status of CHC patients may reduce the prevalence of depression.
KeywordsDepression Chronic hepatitis C Antiviral Hepatitis treatment Adults
The authors thank all participants for their cooperation.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
The study protocol was approved by the Research and Ethics Committee of the Faculty of Medicine, Suez Canal University. All procedures performed in the study were in accordance with the 1964 Helsinki Declaration and its later amendments.
Informed consent was obtained from all individual participants included in the study.
- Beck AT, Sterr R (1984) Internal consistencies of the original and revised Beck Depression Inventory. J Clin Psychol 40:365–367Google Scholar
- Dawson B, Trapp RG (2004) Basic & clinical biostatistics, 4th edn. Lange Medical Books/McGraw-Hill, New YorkGoogle Scholar
- El-Zanaty F, Way A (2009) Egypt demographic and health survey 2008. Ministry of Health, El-Zanaty and Associates, and Macro International, Cairo, 431 pp.Google Scholar
- Gaber M (2014) HCV treatment in Egypt: why cost remains a challenge? Economic and Social Justice Unit, Egyptian Initiative for Personal Rights, CairoGoogle Scholar
- Ghany MG, Nelson DR, Strader DB, Thomas DL, Seeff LB (2011) An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology 54(4):1433–1444. https://doi.org/10.1002/hep.24641 CrossRefPubMedPubMedCentralGoogle Scholar
- Golden J, O’Dwyer AM, Conroy R (2005) Depression and anxiety in patients with hepatitis C: prevalence, detection rates and risk factors. Gen Hosp Psychiatry 27:431–438. https://doi.org/10.1016/j.genhosppsych.2005.06.006 CrossRefPubMedGoogle Scholar
- Metwally AM, Elmosalami DM, Salama SI, Abdel Hameed A, Khalifa A, Hemeda SA (2013) Hepatitis C and depression: does Hepatitis C virus chronic patients need psychological support? J Appl Sci Res 9(1):489–497Google Scholar
- Michaeel NL, Khalil FA, El Nemr NA, Soliman NM (2014) Assessment of health related quality of life and depression among chronic Hepatitis C patients treated with combined pegylated interferon and ribavirin therapy in the Center of Hepatitis C Virus Treatment in Ismailia. Masters degree thesis, Faculty of Medicine, Suez Canal UniversityGoogle Scholar
- Ministry of Health and Population/Egypt, El-Zanaty and Associates/Egypt and ICF International (2015) Egypt health issues survey 2015. Ministry of Health and Population/Egypt and ICF International, Cairo, EgyptGoogle Scholar
- Myrela OM, Giovanni O, Beatrice B, Cristiano AK, Michael M, Marco S (2016) Biological mechanisms of depression following treatment with interferon for chronic hepatitis C: a critical systematic review. J Affect Disord 209. https://doi.org/10.1016/j.jad.2016.11.039
- Qureshi MO, Khokhar N, Shafqat F (2012) Severity of depression in hepatitis B and hepatitis c patients. J College Phys Surg Pakistan 22(10):632–634Google Scholar
- Thein HH, Dore GJ (2010) Cognitive function, mood and health-related quality of life in Hepatitis C virus-infected individuals. In: Preedy VR, Watson RR (eds) Handbook of disease burdens and quality of life measures. Springer, New York, NY. https://doi.org/10.1007/978-0-387-78665-0_191 Google Scholar
- World Health Organization (2014) Guidelines for the screening, care and treatment of persons with hepatitis C infection. World Health Organization, GenevaGoogle Scholar
- World Health Organization (2016) Guidelines for the screening, care and treatment of persons with chronic hepatitis C infection. Updated version, April 2016. World Health Organization, Geneva.Google Scholar
- Youssef NF, El Kassas M, Farag A, Shepherd A (2017) Health-related quality of Life in patients with chronic hepatitis C receiving Sofosbuvir-based treatment, with and without Interferon: a prospective observational study in Egypt. BMC Gastroenterol 17:18. https://doi.org/10.1186/s12876-017-0581-1 CrossRefPubMedPubMedCentralGoogle Scholar